Medications commonly used to combat physical health diseases, such as high blood pressure, could bring significant benefits to people with serious mental illnesses such as schizophrenia and bipolar disorder, a study claims.
The study, published in the journal JAMA Psychiatry, assessed the health data records of 142,691 patients with serious mental illness (SMI) in Sweden.
It focused on those patients who had either been prescribed Hydroxylmethyl glutaryl coenzyme A reductase inhibitors (HMG-CoA RIs), more commonly known as statins — which are used to reduce cholesterol , L-type calcium channel antagonists (LTCC), used to reduce high blood pressure, or
The study, published in the journal JAMA Psychiatry, assessed the health data records of 142,691 patients with serious mental illness (SMI) in Sweden.
It focused on those patients who had either been prescribed Hydroxylmethyl glutaryl coenzyme A reductase inhibitors (HMG-CoA RIs), more commonly known as statins — which are used to reduce cholesterol , L-type calcium channel antagonists (LTCC), used to reduce high blood pressure, or

)